Association between genetic variants in sortilin-related receptor 1 (SORL1) and Alzheimer's disease in adults with Down syndrome

Joseph H. Lee, Maruit Chulikavit, Deborah Pang, Warren B. Zigman, Wayne P Silverman, Nicole Schupf

Research output: Contribution to journalArticle

Abstract

Recent reports have suggested that variants in the sortilin-related receptor gene (SORL1) increase the risk of late onset Alzheimer's disease (AD) in Northern European, Hispanic, African-American and Isreali-Arab populations. SORL1 directs trafficking of amyloid precursor protein (APP) and under-expression of SORL1 may lead to over-expression of β amyloid peptides. Adults with Down syndrome (DS) over-express APP and have early onset and high risk for AD. We investigated the relation of seven variants in the gene for SORL1 to age at onset and risk for AD among 208 adults with DS, 45-70 years of age at baseline. Participants were ascertained through the New York State developmental disability service system and followed at 18-month intervals. Information from cognitive assessments, caregiver interviews, medical record review and neurological examination was used to establish the diagnosis of dementia. Homozygosity for the minor T allele in rs556349 and for the minor C allele in rs536360 was associated with later age at onset and reduced risk of AD (HR = 0.26, 95% CI: 0.08-0.86; and HR = 0.40, 95% CI: 0.16-0.98, respectively). Mean age at onset was approximately four years later in individuals who were homozygous for those alleles compared with those who had at least one major allele. These findings indicate a modest association of variants in SORL1 with AD. In addition, we did not observe the same alleles to be associated with AD compared with earlier studies, suggesting that these SNPs are in linkage disequilibrium (LD) with the putative functional variants or that expression of the SORL1 gene and hence its interaction with APP might be modified by the extremely high levels of APP characteristic of Down syndrome. Thus, further studies are needed to identify functional variants that influence risk for AD in this uniquely vulnerable population.

Original languageEnglish (US)
Pages (from-to)105-109
Number of pages5
JournalNeuroscience Letters
Volume425
Issue number2
DOIs
StatePublished - Sep 25 2007

Fingerprint

Down Syndrome
Alzheimer Disease
Amyloid beta-Protein Precursor
Alleles
Age of Onset
Genes
Developmental Disabilities
Linkage Disequilibrium
Neurologic Examination
Vulnerable Populations
Alzheimer disease type 1
sortilin
Hispanic Americans
Amyloid
African Americans
Caregivers
Medical Records
Single Nucleotide Polymorphism
Dementia
Interviews

Keywords

  • Alzheimer's disease
  • Down syndrome
  • SORL1

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Association between genetic variants in sortilin-related receptor 1 (SORL1) and Alzheimer's disease in adults with Down syndrome. / Lee, Joseph H.; Chulikavit, Maruit; Pang, Deborah; Zigman, Warren B.; Silverman, Wayne P; Schupf, Nicole.

In: Neuroscience Letters, Vol. 425, No. 2, 25.09.2007, p. 105-109.

Research output: Contribution to journalArticle

Lee, Joseph H. ; Chulikavit, Maruit ; Pang, Deborah ; Zigman, Warren B. ; Silverman, Wayne P ; Schupf, Nicole. / Association between genetic variants in sortilin-related receptor 1 (SORL1) and Alzheimer's disease in adults with Down syndrome. In: Neuroscience Letters. 2007 ; Vol. 425, No. 2. pp. 105-109.
@article{b07ebe371cf44e6d9df5ee5ef658d3a8,
title = "Association between genetic variants in sortilin-related receptor 1 (SORL1) and Alzheimer's disease in adults with Down syndrome",
abstract = "Recent reports have suggested that variants in the sortilin-related receptor gene (SORL1) increase the risk of late onset Alzheimer's disease (AD) in Northern European, Hispanic, African-American and Isreali-Arab populations. SORL1 directs trafficking of amyloid precursor protein (APP) and under-expression of SORL1 may lead to over-expression of β amyloid peptides. Adults with Down syndrome (DS) over-express APP and have early onset and high risk for AD. We investigated the relation of seven variants in the gene for SORL1 to age at onset and risk for AD among 208 adults with DS, 45-70 years of age at baseline. Participants were ascertained through the New York State developmental disability service system and followed at 18-month intervals. Information from cognitive assessments, caregiver interviews, medical record review and neurological examination was used to establish the diagnosis of dementia. Homozygosity for the minor T allele in rs556349 and for the minor C allele in rs536360 was associated with later age at onset and reduced risk of AD (HR = 0.26, 95{\%} CI: 0.08-0.86; and HR = 0.40, 95{\%} CI: 0.16-0.98, respectively). Mean age at onset was approximately four years later in individuals who were homozygous for those alleles compared with those who had at least one major allele. These findings indicate a modest association of variants in SORL1 with AD. In addition, we did not observe the same alleles to be associated with AD compared with earlier studies, suggesting that these SNPs are in linkage disequilibrium (LD) with the putative functional variants or that expression of the SORL1 gene and hence its interaction with APP might be modified by the extremely high levels of APP characteristic of Down syndrome. Thus, further studies are needed to identify functional variants that influence risk for AD in this uniquely vulnerable population.",
keywords = "Alzheimer's disease, Down syndrome, SORL1",
author = "Lee, {Joseph H.} and Maruit Chulikavit and Deborah Pang and Zigman, {Warren B.} and Silverman, {Wayne P} and Nicole Schupf",
year = "2007",
month = "9",
day = "25",
doi = "10.1016/j.neulet.2007.08.042",
language = "English (US)",
volume = "425",
pages = "105--109",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Association between genetic variants in sortilin-related receptor 1 (SORL1) and Alzheimer's disease in adults with Down syndrome

AU - Lee, Joseph H.

AU - Chulikavit, Maruit

AU - Pang, Deborah

AU - Zigman, Warren B.

AU - Silverman, Wayne P

AU - Schupf, Nicole

PY - 2007/9/25

Y1 - 2007/9/25

N2 - Recent reports have suggested that variants in the sortilin-related receptor gene (SORL1) increase the risk of late onset Alzheimer's disease (AD) in Northern European, Hispanic, African-American and Isreali-Arab populations. SORL1 directs trafficking of amyloid precursor protein (APP) and under-expression of SORL1 may lead to over-expression of β amyloid peptides. Adults with Down syndrome (DS) over-express APP and have early onset and high risk for AD. We investigated the relation of seven variants in the gene for SORL1 to age at onset and risk for AD among 208 adults with DS, 45-70 years of age at baseline. Participants were ascertained through the New York State developmental disability service system and followed at 18-month intervals. Information from cognitive assessments, caregiver interviews, medical record review and neurological examination was used to establish the diagnosis of dementia. Homozygosity for the minor T allele in rs556349 and for the minor C allele in rs536360 was associated with later age at onset and reduced risk of AD (HR = 0.26, 95% CI: 0.08-0.86; and HR = 0.40, 95% CI: 0.16-0.98, respectively). Mean age at onset was approximately four years later in individuals who were homozygous for those alleles compared with those who had at least one major allele. These findings indicate a modest association of variants in SORL1 with AD. In addition, we did not observe the same alleles to be associated with AD compared with earlier studies, suggesting that these SNPs are in linkage disequilibrium (LD) with the putative functional variants or that expression of the SORL1 gene and hence its interaction with APP might be modified by the extremely high levels of APP characteristic of Down syndrome. Thus, further studies are needed to identify functional variants that influence risk for AD in this uniquely vulnerable population.

AB - Recent reports have suggested that variants in the sortilin-related receptor gene (SORL1) increase the risk of late onset Alzheimer's disease (AD) in Northern European, Hispanic, African-American and Isreali-Arab populations. SORL1 directs trafficking of amyloid precursor protein (APP) and under-expression of SORL1 may lead to over-expression of β amyloid peptides. Adults with Down syndrome (DS) over-express APP and have early onset and high risk for AD. We investigated the relation of seven variants in the gene for SORL1 to age at onset and risk for AD among 208 adults with DS, 45-70 years of age at baseline. Participants were ascertained through the New York State developmental disability service system and followed at 18-month intervals. Information from cognitive assessments, caregiver interviews, medical record review and neurological examination was used to establish the diagnosis of dementia. Homozygosity for the minor T allele in rs556349 and for the minor C allele in rs536360 was associated with later age at onset and reduced risk of AD (HR = 0.26, 95% CI: 0.08-0.86; and HR = 0.40, 95% CI: 0.16-0.98, respectively). Mean age at onset was approximately four years later in individuals who were homozygous for those alleles compared with those who had at least one major allele. These findings indicate a modest association of variants in SORL1 with AD. In addition, we did not observe the same alleles to be associated with AD compared with earlier studies, suggesting that these SNPs are in linkage disequilibrium (LD) with the putative functional variants or that expression of the SORL1 gene and hence its interaction with APP might be modified by the extremely high levels of APP characteristic of Down syndrome. Thus, further studies are needed to identify functional variants that influence risk for AD in this uniquely vulnerable population.

KW - Alzheimer's disease

KW - Down syndrome

KW - SORL1

UR - http://www.scopus.com/inward/record.url?scp=34548617769&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548617769&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2007.08.042

DO - 10.1016/j.neulet.2007.08.042

M3 - Article

C2 - 17826910

AN - SCOPUS:34548617769

VL - 425

SP - 105

EP - 109

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 2

ER -